Wellington Management Group
AVEO

Wellington Management Group’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Wellington Management Group’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-22,988
Closed -$344K – 2162
2022
Q4 		$344K Buy
+22,988
New +$318K ﹤0.01% 1871
2013
Q4 		– Sell
-54,954
Closed -$1.14M – 2260
2013
Q3 		$1.14M Sell
54,954
-47,989
-47% -$1.1M ﹤0.01% 1768
2013
Q2 		$2.57M Buy
+102,943
New +$4.4M ﹤0.01% 1587

Wellington Management Group's AVEO Position: Q1 2023 in Review

Wellington Management Group sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 22,988 shares — an estimated $344K sold.

Wellington Management Group first reported a position in AVEO in Q2 2013 and held it in 3 quarters. The position peaked at $2.57M in Q2 2013. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Wellington Management Group reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Wellington Management Group sold 22,988 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $344K.
  • Wellington Management Group first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 3 quarters.
  • Wellington Management Group's AVEO Pharmaceuticals, Inc. position peaked at $2.57M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Wellington Management Group's 13F filing for Q1 2023, filed 12 May 2023.